APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Ingredient

Compare research editions
View pricing & licenses

Selected research

Industry Research

Immune Health Ingredient Industry Research Report 2026

Report ID 174001930522 December 2025144 pages

Choose your research edition.

Industry ResearchImmune Health Ingredient Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Ingredient Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Immune Health Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Ingredient Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Ingredient Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Immune Health Ingredient market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Immune Health Ingredient is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Immune Health Ingredient is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Immune Health Ingredient include ADM, Arla Foods, Associated British Foods, Balchem, Cargill, Chr. Hansen, Divis Laboratories, DSM and Glanbia PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Immune Health Ingredient market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Immune Health Ingredient Market by Company

ADM

Arla Foods

Associated British Foods

Balchem

Cargill

Chr. Hansen

Divis Laboratories

DSM

Glanbia PLC

Ingredion

International Flavors & Fragrances

Kerry Group PLC

MartinBauer

Roquette

ROYAL FRIESLANDCAMPINA N.V.

Tate & Lyle

BASF

Fonterra

Lonza

Probi

Immune Health Ingredient Segment by Type

Plant & Fruit Extracts

Nutritional Lipids

Prebiotics

Probiotic Starter Cultures

Vitamins

Minerals

Enzymes

Functional Carbohydrates

Proteins

Immune Health Ingredient Segment by Application

Beverages

Pharmaceuticals

Feed

Food

Others

Immune Health Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Immune Health Ingredient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Immune Health Ingredient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Immune Health Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Immune Health Ingredient Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Immune Health Ingredient Sales (k units) of Manufacturers (2021-2026) Table 7. Global Immune Health Ingredient Sales Market Share by Manufacturers (2021-2026) Table 8. Global Immune Health Ingredient Revenue of Manufacturers (2021-2026) Table 9. Global Immune Health Ingredient Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Immune Health Ingredient Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Immune Health Ingredient Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Immune Health Ingredient, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Immune Health Ingredient, Product Type & Application Table 14. Global Immune Health Ingredient Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Immune Health Ingredient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ADM Company Information Table 19. ADM Business Overview Table 20. ADM Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. ADM Immune Health Ingredient Product Portfolio Table 22. ADM Recent Developments Table 23. Arla Foods Company Information Table 24. Arla Foods Business Overview Table 25. Arla Foods Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Arla Foods Immune Health Ingredient Product Portfolio Table 27. Arla Foods Recent Developments Table 28. Associated British Foods Company Information Table 29. Associated British Foods Business Overview Table 30. Associated British Foods Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Associated British Foods Immune Health Ingredient Product Portfolio Table 32. Associated British Foods Recent Developments Table 33. Balchem Company Information Table 34. Balchem Business Overview Table 35. Balchem Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Balchem Immune Health Ingredient Product Portfolio Table 37. Balchem Recent Developments Table 38. Cargill Company Information Table 39. Cargill Business Overview Table 40. Cargill Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Cargill Immune Health Ingredient Product Portfolio Table 42. Cargill Recent Developments Table 43. Chr. Hansen Company Information Table 44. Chr. Hansen Business Overview Table 45. Chr. Hansen Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Chr. Hansen Immune Health Ingredient Product Portfolio Table 47. Chr. Hansen Recent Developments Table 48. Divis Laboratories Company Information Table 49. Divis Laboratories Business Overview Table 50. Divis Laboratories Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Divis Laboratories Immune Health Ingredient Product Portfolio Table 52. Divis Laboratories Recent Developments Table 53. DSM Company Information Table 54. DSM Business Overview Table 55. DSM Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. DSM Immune Health Ingredient Product Portfolio Table 57. DSM Recent Developments Table 58. Glanbia PLC Company Information Table 59. Glanbia PLC Business Overview Table 60. Glanbia PLC Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Glanbia PLC Immune Health Ingredient Product Portfolio Table 62. Glanbia PLC Recent Developments Table 63. Ingredion Company Information Table 64. Ingredion Business Overview Table 65. Ingredion Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Ingredion Immune Health Ingredient Product Portfolio Table 67. Ingredion Recent Developments Table 68. International Flavors & Fragrances Company Information Table 69. International Flavors & Fragrances Business Overview Table 70. International Flavors & Fragrances Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. International Flavors & Fragrances Immune Health Ingredient Product Portfolio Table 72. International Flavors & Fragrances Recent Developments Table 73. Kerry Group PLC Company Information Table 74. Kerry Group PLC Business Overview Table 75. Kerry Group PLC Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Kerry Group PLC Immune Health Ingredient Product Portfolio Table 77. Kerry Group PLC Recent Developments Table 78. MartinBauer Company Information Table 79. MartinBauer Business Overview Table 80. MartinBauer Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. MartinBauer Immune Health Ingredient Product Portfolio Table 82. MartinBauer Recent Developments Table 83. Roquette Company Information Table 84. Roquette Business Overview Table 85. Roquette Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Roquette Immune Health Ingredient Product Portfolio Table 87. Roquette Recent Developments Table 88. ROYAL FRIESLANDCAMPINA N.V. Company Information Table 89. ROYAL FRIESLANDCAMPINA N.V. Business Overview Table 90. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio Table 92. ROYAL FRIESLANDCAMPINA N.V. Recent Developments Table 93. Tate & Lyle Company Information Table 94. Tate & Lyle Business Overview Table 95. Tate & Lyle Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Tate & Lyle Immune Health Ingredient Product Portfolio Table 97. Tate & Lyle Recent Developments Table 98. BASF Company Information Table 99. BASF Business Overview Table 100. BASF Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. BASF Immune Health Ingredient Product Portfolio Table 102. BASF Recent Developments Table 103. Fonterra Company Information Table 104. Fonterra Business Overview Table 105. Fonterra Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Fonterra Immune Health Ingredient Product Portfolio Table 107. Fonterra Recent Developments Table 108. Lonza Company Information Table 109. Lonza Business Overview Table 110. Lonza Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Lonza Immune Health Ingredient Product Portfolio Table 112. Lonza Recent Developments Table 113. Probi Company Information Table 114. Probi Business Overview Table 115. Probi Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Probi Immune Health Ingredient Product Portfolio Table 117. Probi Recent Developments Table 118. Global Immune Health Ingredient Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Immune Health Ingredient Sales by Region (2021-2026) & (k units) Table 120. Global Immune Health Ingredient Sales Market Share by Region (2021-2026) Table 121. Global Immune Health Ingredient Sales by Region (2027-2032) & (k units) Table 122. Global Immune Health Ingredient Sales Market Share by Region (2027-2032) Table 123. Global Immune Health Ingredient Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Immune Health Ingredient Revenue Market Share by Region (2021-2026) Table 125. Global Immune Health Ingredient Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Immune Health Ingredient Revenue Market Share by Region (2027-2032) Table 127. North America Immune Health Ingredient Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 129. North America Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 130. North America Immune Health Ingredient Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Immune Health Ingredient Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Immune Health Ingredient Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 134. Europe Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 135. Europe Immune Health Ingredient Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Immune Health Ingredient Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Immune Health Ingredient Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 139. Asia Pacific Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 140. Asia Pacific Immune Health Ingredient Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Immune Health Ingredient Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Immune Health Ingredient Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 144. South America Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 145. South America Immune Health Ingredient Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Immune Health Ingredient Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Immune Health Ingredient Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 150. Middle East and Africa Immune Health Ingredient Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Immune Health Ingredient Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 153. Global Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 154. Global Immune Health Ingredient Sales Market Share by Type (2021-2026) Table 155. Global Immune Health Ingredient Sales Market Share by Type (2027-2032) Table 156. Global Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Immune Health Ingredient Revenue Market Share by Type (2021-2026) Table 159. Global Immune Health Ingredient Revenue Market Share by Type (2027-2032) Table 160. Global Immune Health Ingredient Price by Type (2021-2026) & (US$/unit) Table 161. Global Immune Health Ingredient Price by Type (2027-2032) & (US$/unit) Table 162. Global Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 163. Global Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 164. Global Immune Health Ingredient Sales Market Share by Application (2021-2026) Table 165. Global Immune Health Ingredient Sales Market Share by Application (2027-2032) Table 166. Global Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Immune Health Ingredient Revenue Market Share by Application (2021-2026) Table 169. Global Immune Health Ingredient Revenue Market Share by Application (2027-2032) Table 170. Global Immune Health Ingredient Price by Application (2021-2026) & (US$/unit) Table 171. Global Immune Health Ingredient Price by Application (2027-2032) & (US$/unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Immune Health Ingredient Distributors List Table 175. Immune Health Ingredient Customers List Table 176. Immune Health Ingredient Industry Trends Table 177. Immune Health Ingredient Industry Drivers Table 178. Immune Health Ingredient Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Immune Health Ingredient Product Image Figure 5. Global Immune Health Ingredient Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Immune Health Ingredient Market Size (2021-2032) & (US$ Million) Figure 7. Global Immune Health Ingredient Sales (2021-2032) & (k units) Figure 8. Global Immune Health Ingredient Average Price (US$/unit) & (2021-2032) Figure 9. Plant & Fruit Extracts Product Image Figure 10. Nutritional Lipids Product Image Figure 11. Prebiotics Product Image Figure 12. Probiotic Starter Cultures Product Image Figure 13. Vitamins Product Image Figure 14. Minerals Product Image Figure 15. Enzymes Product Image Figure 16. Functional Carbohydrates Product Image Figure 17. Proteins Product Image Figure 18. Beverages Product Image Figure 19. Pharmaceuticals Product Image Figure 20. Feed Product Image Figure 21. Food Product Image Figure 22. Others Product Image Figure 23. Global Immune Health Ingredient Revenue Share by Manufacturers in 2025 Figure 24. Global Manufacturers of Immune Health Ingredient, Manufacturing Sites & Headquarters Figure 25. Global Top 5 and 10 Immune Health Ingredient Players Market Share by Revenue in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Immune Health Ingredient Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 28. Global Immune Health Ingredient Sales by Region in 2025 Figure 29. Global Immune Health Ingredient Revenue by Region in 2025 Figure 30. North America Immune Health Ingredient Market Size by Country in 2025 Figure 31. North America Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 32. North America Immune Health Ingredient Revenue Market Share by Country (2021-2032) Figure 33. United States Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Mexico Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Europe Immune Health Ingredient Market Size by Country in 2025 Figure 37. Europe Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 38. Europe Immune Health Ingredient Revenue Market Share by Country (2021-2032) Figure 39. Germany Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. France Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. U.K. Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Italy Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Russia Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Spain Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Netherlands Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Switzerland Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Sweden Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Poland Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Asia Pacific Immune Health Ingredient Market Size by Country in 2025 Figure 50. Asia Pacific Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 51. Asia Pacific Immune Health Ingredient Revenue Market Share by Country (2021-2032) Figure 52. China Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Japan Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South Korea Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. India Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Australia Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Taiwan Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Southeast Asia Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Southeast Asia Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South America Immune Health Ingredient Market Size by Country in 2025 Figure 61. South America Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 62. South America Immune Health Ingredient Revenue Market Share by Country (2021-2032) Figure 63. Brazil Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Argentina Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Chile Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Middle East and Africa Immune Health Ingredient Market Size by Country in 2025 Figure 67. Middle East and Africa Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 68. Middle East and Africa Immune Health Ingredient Revenue Market Share by Country (2021-2032) Figure 69. Egypt Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. South Africa Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Israel Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Türkiye Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 73. GCC Countries Immune Health Ingredient Revenue Growth Rate (2021-2032) & (US$ Million) Figure 74. Global Immune Health Ingredient Sales Market Share by Type (2021-2032) Figure 75. Global Immune Health Ingredient Revenue Market Share by Type (2021-2032) Figure 76. Global Immune Health Ingredient Price (US$/unit) by Type (2021-2032) Figure 77. Global Immune Health Ingredient Sales Market Share by Application (2021-2032) Figure 78. Global Immune Health Ingredient Revenue Market Share by Application (2021-2032) Figure 79. Global Immune Health Ingredient Price (US$/unit) by Application (2021-2032) Figure 80. Immune Health Ingredient Value Chain Figure 81. Immune Health Ingredient Production Mode & Process Figure 82. Direct Comparison with Distribution Share Figure 83. Distributors Profiles Figure 84. Immune Health Ingredient Industry Opportunities and Challenges

Scope & coverage.

Types
  • Plant & Fruit Extracts
  • Nutritional Lipids
  • Prebiotics
  • Probiotic Starter Cultures
  • Vitamins
  • Minerals
  • Enzymes
  • Functional Carbohydrates
  • Proteins
Applications
  • Beverages
  • Pharmaceuticals
  • Feed
  • Food
  • Others
Companies covered
  • ADM
  • Arla Foods
  • Associated British Foods
  • Balchem
  • Cargill
  • Chr. Hansen
  • Divis Laboratories
  • DSM
  • Glanbia PLC
  • Ingredion
  • International Flavors & Fragrances
  • Kerry Group PLC
  • MartinBauer
  • Roquette
  • ROYAL FRIESLANDCAMPINA N.V.
  • Tate & Lyle
  • BASF
  • Fonterra
  • Lonza
  • Probi

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Immune Health Ingredient Market Size (2021-2032)
  4. 2.2.2 Global Immune Health Ingredient Sales (2021-2032)
  5. 2.2.3 Global Immune Health Ingredient Market Average Price (2021-2032)
  6. 2.3 Immune Health Ingredient by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Plant & Fruit Extracts
  9. 2.3.3 Nutritional Lipids
  10. 2.3.4 Prebiotics
  11. 2.3.5 Probiotic Starter Cultures
  12. 2.3.6 Vitamins
  13. 2.3.7 Minerals
  14. 2.3.8 Enzymes
  15. 2.3.9 Functional Carbohydrates
  16. 2.3.10 Proteins
  17. 2.4 Immune Health Ingredient by Application
  18. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  19. 2.4.2 Beverages
  20. 2.4.3 Pharmaceuticals
  21. 2.4.4 Feed
  22. 2.4.5 Food
  23. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Immune Health Ingredient Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Immune Health Ingredient Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Immune Health Ingredient Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Immune Health Ingredient Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Immune Health Ingredient Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Immune Health Ingredient, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Immune Health Ingredient, Product Type & Application
  8. 3.8 Global Manufacturers of Immune Health Ingredient, Established Date
  9. 3.9 Global Immune Health Ingredient Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ADM
  2. 4.1.1 ADM Company Information
  3. 4.1.2 ADM Business Overview
  4. 4.1.3 ADM Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ADM Immune Health Ingredient Product Portfolio
  6. 4.1.5 ADM Recent Developments
  7. 4.2 Arla Foods
  8. 4.2.1 Arla Foods Company Information
  9. 4.2.2 Arla Foods Business Overview
  10. 4.2.3 Arla Foods Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Arla Foods Immune Health Ingredient Product Portfolio
  12. 4.2.5 Arla Foods Recent Developments
  13. 4.3 Associated British Foods
  14. 4.3.1 Associated British Foods Company Information
  15. 4.3.2 Associated British Foods Business Overview
  16. 4.3.3 Associated British Foods Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Associated British Foods Immune Health Ingredient Product Portfolio
  18. 4.3.5 Associated British Foods Recent Developments
  19. 4.4 Balchem
  20. 4.4.1 Balchem Company Information
  21. 4.4.2 Balchem Business Overview
  22. 4.4.3 Balchem Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Balchem Immune Health Ingredient Product Portfolio
  24. 4.4.5 Balchem Recent Developments
  25. 4.5 Cargill
  26. 4.5.1 Cargill Company Information
  27. 4.5.2 Cargill Business Overview
  28. 4.5.3 Cargill Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cargill Immune Health Ingredient Product Portfolio
  30. 4.5.5 Cargill Recent Developments
  31. 4.6 Chr. Hansen
  32. 4.6.1 Chr. Hansen Company Information
  33. 4.6.2 Chr. Hansen Business Overview
  34. 4.6.3 Chr. Hansen Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Chr. Hansen Immune Health Ingredient Product Portfolio
  36. 4.6.5 Chr. Hansen Recent Developments
  37. 4.7 Divis Laboratories
  38. 4.7.1 Divis Laboratories Company Information
  39. 4.7.2 Divis Laboratories Business Overview
  40. 4.7.3 Divis Laboratories Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Divis Laboratories Immune Health Ingredient Product Portfolio
  42. 4.7.5 Divis Laboratories Recent Developments
  43. 4.8 DSM
  44. 4.8.1 DSM Company Information
  45. 4.8.2 DSM Business Overview
  46. 4.8.3 DSM Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DSM Immune Health Ingredient Product Portfolio
  48. 4.8.5 DSM Recent Developments
  49. 4.9 Glanbia PLC
  50. 4.9.1 Glanbia PLC Company Information
  51. 4.9.2 Glanbia PLC Business Overview
  52. 4.9.3 Glanbia PLC Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Glanbia PLC Immune Health Ingredient Product Portfolio
  54. 4.9.5 Glanbia PLC Recent Developments
  55. 4.10 Ingredion
  56. 4.10.1 Ingredion Company Information
  57. 4.10.2 Ingredion Business Overview
  58. 4.10.3 Ingredion Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ingredion Immune Health Ingredient Product Portfolio
  60. 4.10.5 Ingredion Recent Developments
  61. 4.11 International Flavors & Fragrances
  62. 4.11.1 International Flavors & Fragrances Company Information
  63. 4.11.2 International Flavors & Fragrances Business Overview
  64. 4.11.3 International Flavors & Fragrances Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 International Flavors & Fragrances Immune Health Ingredient Product Portfolio
  66. 4.11.5 International Flavors & Fragrances Recent Developments
  67. 4.12 Kerry Group PLC
  68. 4.12.1 Kerry Group PLC Company Information
  69. 4.12.2 Kerry Group PLC Business Overview
  70. 4.12.3 Kerry Group PLC Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Kerry Group PLC Immune Health Ingredient Product Portfolio
  72. 4.12.5 Kerry Group PLC Recent Developments
  73. 4.13 MartinBauer
  74. 4.13.1 MartinBauer Company Information
  75. 4.13.2 MartinBauer Business Overview
  76. 4.13.3 MartinBauer Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 MartinBauer Immune Health Ingredient Product Portfolio
  78. 4.13.5 MartinBauer Recent Developments
  79. 4.14 Roquette
  80. 4.14.1 Roquette Company Information
  81. 4.14.2 Roquette Business Overview
  82. 4.14.3 Roquette Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Roquette Immune Health Ingredient Product Portfolio
  84. 4.14.5 Roquette Recent Developments
  85. 4.15 ROYAL FRIESLANDCAMPINA N.V.
  86. 4.15.1 ROYAL FRIESLANDCAMPINA N.V. Company Information
  87. 4.15.2 ROYAL FRIESLANDCAMPINA N.V. Business Overview
  88. 4.15.3 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio
  90. 4.15.5 ROYAL FRIESLANDCAMPINA N.V. Recent Developments
  91. 4.16 Tate & Lyle
  92. 4.16.1 Tate & Lyle Company Information
  93. 4.16.2 Tate & Lyle Business Overview
  94. 4.16.3 Tate & Lyle Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Tate & Lyle Immune Health Ingredient Product Portfolio
  96. 4.16.5 Tate & Lyle Recent Developments
  97. 4.17 BASF
  98. 4.17.1 BASF Company Information
  99. 4.17.2 BASF Business Overview
  100. 4.17.3 BASF Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 BASF Immune Health Ingredient Product Portfolio
  102. 4.17.5 BASF Recent Developments
  103. 4.18 Fonterra
  104. 4.18.1 Fonterra Company Information
  105. 4.18.2 Fonterra Business Overview
  106. 4.18.3 Fonterra Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Fonterra Immune Health Ingredient Product Portfolio
  108. 4.18.5 Fonterra Recent Developments
  109. 4.19 Lonza
  110. 4.19.1 Lonza Company Information
  111. 4.19.2 Lonza Business Overview
  112. 4.19.3 Lonza Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Lonza Immune Health Ingredient Product Portfolio
  114. 4.19.5 Lonza Recent Developments
  115. 4.20 Probi
  116. 4.20.1 Probi Company Information
  117. 4.20.2 Probi Business Overview
  118. 4.20.3 Probi Immune Health Ingredient Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Probi Immune Health Ingredient Product Portfolio
  120. 4.20.5 Probi Recent Developments
5 Global Immune Health Ingredient Market Scenario by Region
  1. 5.1 Global Immune Health Ingredient Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Immune Health Ingredient Sales by Region: 2021-2032
  3. 5.2.1 Global Immune Health Ingredient Sales by Region: 2021-2026
  4. 5.2.2 Global Immune Health Ingredient Sales by Region: 2027-2032
  5. 5.3 Global Immune Health Ingredient Revenue by Region: 2021-2032
  6. 5.3.1 Global Immune Health Ingredient Revenue by Region: 2021-2026
  7. 5.3.2 Global Immune Health Ingredient Revenue by Region: 2027-2032
  8. 5.4 North America Immune Health Ingredient Market Facts & Figures by Country
  9. 5.4.1 North America Immune Health Ingredient Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Immune Health Ingredient Sales by Country (2021-2032)
  11. 5.4.3 North America Immune Health Ingredient Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Immune Health Ingredient Market Facts & Figures by Country
  16. 5.5.1 Europe Immune Health Ingredient Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Immune Health Ingredient Sales by Country (2021-2032)
  18. 5.5.3 Europe Immune Health Ingredient Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Immune Health Ingredient Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Immune Health Ingredient Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Immune Health Ingredient Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Immune Health Ingredient Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Immune Health Ingredient Market Facts & Figures by Country
  41. 5.7.1 South America Immune Health Ingredient Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Immune Health Ingredient Sales by Country (2021-2032)
  43. 5.7.3 South America Immune Health Ingredient Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Immune Health Ingredient Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Immune Health Ingredient Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Immune Health Ingredient Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Immune Health Ingredient Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Immune Health Ingredient Sales by Type (2021-2032)
  2. 6.1.1 Global Immune Health Ingredient Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Immune Health Ingredient Sales Market Share by Type (2021-2032)
  4. 6.2 Global Immune Health Ingredient Revenue by Type (2021-2032)
  5. 6.2.1 Global Immune Health Ingredient Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Immune Health Ingredient Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Immune Health Ingredient Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Immune Health Ingredient Sales by Application (2021-2032)
  2. 7.1.1 Global Immune Health Ingredient Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Immune Health Ingredient Sales Market Share by Application (2021-2032)
  4. 7.2 Global Immune Health Ingredient Revenue by Application (2021-2032)
  5. 7.2.1 Global Immune Health Ingredient Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Immune Health Ingredient Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Immune Health Ingredient Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Immune Health Ingredient Value Chain Analysis
  2. 8.1.1 Immune Health Ingredient Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Immune Health Ingredient Production Mode & Process
  5. 8.2 Immune Health Ingredient Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Immune Health Ingredient Distributors
  8. 8.2.3 Immune Health Ingredient Customers
9 Global Immune Health Ingredient Analyzing Market Dynamics
  1. 9.1 Immune Health Ingredient Industry Trends
  2. 9.2 Immune Health Ingredient Industry Drivers
  3. 9.3 Immune Health Ingredient Industry Opportunities and Challenges
  4. 9.4 Immune Health Ingredient Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst